All stock lists
Five9, Inc. (NASDAQ:FIVN)
US · Delayed Price · Currency is USD
Also listed: 0TMV.LTechnology · Software - Application
37.89+0.28 (+0.74%)
Insider Score
––Not scored
FIVN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
FIVN analyst forecast
FIVN analyst consensus
Moderate Buy11 ratings
Buy 7 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
FIVN 12-month price target
$40.25+6.6% upsideaverage of 4 firms
$48.00High
$33.00Low
Best analysts covering FIVN
- Barclays29%success rate · 7 calls
- Canaccord Genuity25%success rate · 4 calls
- Piper Sandler15%success rate · 13 calls
- Truist Securities14%success rate · 7 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
FIVN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | Buy | $48.00 | +48.6% | Reiterated | 2026-10-16 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-13 |
| D.A. Davidson | — | $33.00 | -5.5% | — | 2026-09-28 | |
| Cantor Fitzgerald | Overweight | $40.00 | +18.6% | Reiterated | 2026-09-21 | |
| FBN Securities | — | $40.00 | +21.1% | — | 2026-09-16 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-31 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-08-25 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-24 |
| — | Baird | Neutral | — | — | Reiterated | 2026-08-10 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-08-10 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-10 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-07 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2026-08-07 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-08-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-07 |
| — | UBS | Buy | — | — | Reiterated | 2026-08-07 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-08-07 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2026-06-24 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2026-05-05 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-05-01 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-05-01 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-05-01 |
| — | UBS | Buy | — | — | Reiterated | 2026-05-01 |
| — | Needham | Buy | — | — | Reiterated | 2026-05-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-21 |
| — | Baird | Neutral | — | — | Reiterated | 2026-02-23 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-20 |
| — | UBS | Buy | — | — | Reiterated | 2026-02-20 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-02-20 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-02-20 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-02-20 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-20 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2026-02-20 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-02-20 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-02-20 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-01-15 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-12 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2026-01-05 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-07 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-11-07 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-07 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-11-07 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-09-12 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2025-08-01 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-08-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-07-14 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2025-05-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-05-05 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2025-05-02 |
| — | UBS | Buy | — | — | Reiterated | 2025-05-02 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-05-02 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-05-02 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-02 |
| — | Jefferies | Hold | — | — | Reiterated | 2025-04-28 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2025-04-24 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-04-22 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-04-16 |
| — | Mizuho | Outperform | — | — | Reiterated | 2025-04-15 |
| — | Rosenblatt | Buy | — | — | Reiterated | 2025-04-04 |
FIVN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-19 | 0.79 | 0.80 | $298.1M | $300.3M |
| 2026-04-30 | 0.69 | 0.76 | $299.9M | $305.3M |
| 2026-08-06 | 0.68 | 0.70 | $306.6M | $312.4M |
| 2026-11-09 | 0.80 | 0.00 | $319.0M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.